Natraj Proteins returns to profit in FY26
Natraj Proteins Limited reported a net profit of ₹113.51 lakh for FY26, reversing the previous year's loss of ₹146.27 lakh. Annual income from operations stood at ₹10112.13 lakh, while Q4 profit was ₹110.84 lakh on revenue of ₹1887.26 lakh.

*this image is generated using AI for illustrative purposes only.
Natraj Proteins Limited has announced its audited financial results for the year ended March 31, 2026, reporting a return to profitability. The company recorded a net profit of ₹113.51 lakh for the full fiscal year, a significant turnaround from the net loss of ₹146.27 lakh posted in the previous year ended March 31, 2025.
The board of directors approved the financial results during a meeting held on May 22, 2026. Total income from operations for FY26 stood at ₹10112.13 lakh, a decrease from the ₹11778.29 lakh reported in the prior year. Despite the lower revenue, improved cost management and operational efficiency contributed to the positive bottom line.
Financial Performance
The company's paid-up equity share capital remained constant at ₹374.70 lakh with a face value of ₹10 per share. Reserves, excluding revaluation reserve, increased to ₹2959.03 lakh as of March 31, 2026, compared to ₹2848.00 lakh in the previous year.
For the fourth quarter ended March 31, 2026, Natraj Proteins reported a net profit of ₹110.84 lakh. Total income for the quarter was ₹1887.26 lakh. The earnings per share (EPS) for the year improved to ₹3.03 from a negative ₹3.9 in the previous year.
Key Financial Metrics
| Particulars | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|
| Total income from operations | ₹10112.13 lakh | ₹11778.29 lakh |
| Net Profit for the period | ₹113.51 lakh | ₹-146.27 lakh |
| Paid up Equity Share Capital | ₹374.70 lakh | ₹374.70 lakh |
| Reserves | ₹2959.03 lakh | ₹2848.00 lakh |
| Basic EPS | ₹3.03 | ₹(3.9) |
The detailed financial results are available on the company's website and the BSE platform.
Historical Stock Returns for Natraj Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +6.83% | +5.42% | +6.29% | +9.87% | +0.12% | -32.50% |
What specific cost management strategies did Natraj Proteins implement in FY26, and are these measures sustainable enough to maintain profitability despite declining revenues in FY27?
Will Natraj Proteins announce a dividend for FY26 given the return to profitability, and how might this impact investor sentiment toward the stock?
What is driving the ~14% decline in revenue from operations, and does management have a concrete plan to reverse this downward trend in FY27?






























